You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Positive results for Evgen’s rhabdomyosarcoma therapy

Evgen Pharma has issued an update on its research partnership with Sapienza University of Rome, which has been concentrating on the radiosensitising impact of SFX-01 in-vivo when treating rhabdomyosarcoma (RMS).